Loading...

STLL

MSL

SATELLOS BIOSCIENCE INC

(MSLE)

2026 6-K

Interim Financial Report

15 May '26

Investor Conference

9 Apr '26

Financial Report

27 Mar '26

Clinical Data Update

10 Mar '26

Conference Announcement

24 Feb '26

Investor Conferences

19 Feb '26

KOL Event Announcement

18 Feb '26

Filing Submission

17 Feb '26

Pediatric Study Update

12 Feb '26

Biotech Summit Participation

10 Feb '26

Public Offering Completed

9 Feb '26

Filing Update

6 Feb '26

External Links:

SEC

Satellos Bioscience Inc. filed a report on March 10, 2026, presenting interim clinical and biomarker data for SAT-3247 in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference.

AI Assistant

SATELLOS BIOSCIENCE INC

2026

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.